ArticleJournal of the American Chemical Society2025
Highly Branched Sulfated Glycopolymers as Mucin Mimetics.
Article in Journal of the American Chemical Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Morphology controls nonlinear donor acceptor thermodynamics in divinylbenzene-based copolymers.iScience · 2026Article
- Glycoengineering strategies for constructing defined Mucin O-glycans.Frontiers in molecular biosciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mucins are highly complex glycoproteins that form protective and lubricating barriers around epithelial surfaces, e.g., in the respiratory tract, to protect against pathogens. The isolation and purification of natural mucins without compromising their structure and thus their properties remain challenging. Glycopolymers as mucin mimetics have shown great potential in biomedical research, for example, in mucosal barrier enhancement and respiratory disease treatment, or in improving surface lubrication and adhesion properties. Here, we introduce double-brushed mucin mimetic glycopolymers, replicating for the first time a structural design that more closely imitates key architectural features of natural mucins. By combining solid-phase synthesis of sequence-defined glycooligomers and their attachment onto polyactive ester scaffolds, we enable access to a library of linear, brushed, and double-brushed glycopolymers with controlled variations of structural parameters, such as overall chain length, number, and length of branches, as well as number of carbohydrates and degree of sulfation. By using light and neutron scattering as well as atomic force microscopy-based single-molecule force spectroscopy and imaging, we can demonstrate that the double-brushed architecture is responsible for successfully mimicking critical mucin properties, such as their adhesion to hydrophilic surfaces and an extended conformation, properties that are not achieved with single-brushed or linear analogues. Thus, our findings show that double-brushed sulfated glycopolymers effectively replicate key characteristics of natural mucins, advancing their potential as mucin models, as well as for use in biomedical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.